Tag Archives: Foundation Medicine

Roche commences cash tender offer for up to 15,604,288 outstanding shares of common stock of Foundation Medicine, Inc. at a price of $50.00 per share

Posted on 3, February 2015 by

BASEL, 3-2-2015 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cash tender offer for up to 15,604,288 outstanding shares of common stock of Foundation Medicine, Inc. (NASDAQ: FMI) at a price of … Read the full press release →

Posted in Business, Financial, Healthcare, Management, Pharma & Biotech, Switzerland

Tagged , , , ,

Roche to acquire up to 56.3% interest in Foundation Medicine, Inc. on a fully diluted basis through a tender and acquisition of newly issued shares

Posted on 12, January 2015 by

BASEL, 12-1-2015 — /EuropaWire/ — Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer Roche to acquire a majority interest in Foundation Medicine (FMI) of up to 56.3% on a fully diluted basis … Read the full press release →

Posted in Healthcare, Management, Pharma & Biotech, Sweden

Tagged , , , ,